Sanara MedTech Inc. (SMTI) Guidance & Earnings Results
On 2026-05-11 Sanara MedTech Inc. reaffirmed guidance: "FY26 net revenue $116-121M (13-17%…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
SMTISanara MedTech Inc.Follow SMTI — free
—
Price chart with a free account
- Market cap
- 301.4M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 16 Nov, in 23 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 11 May 26 | Reaffirmed | FY26 net revenue $116-121M (13-17% growth) · full year |
| 24 Mar 26 | Reaffirmed | FY2026 net revenue $116-121M (13-17% growth vs $103.1M in FY2025) · full year |
| 23 Jan 26 | Raised | FY2026 net revenue $116-121M, growth ~13-17% vs FY2025 midpoint (~$103M) · full year |
Sanara MedTech Inc. — questions
- What guidance did Sanara MedTech Inc. give?
- On 2026-05-11: "FY26 net revenue $116-121M (13-17% growth)"
- When does Sanara MedTech Inc. report earnings?
- Sanara MedTech Inc.'s next earnings report is expected on 2026-11-16.
Every figure on this page comes from Sanara MedTech Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.